青少年异染性脑白质营养不良造血干细胞移植后临床结局的多参数MRI分析
这项回顾性、基于注册的队列研究纳入15例青少年异染性脑白质营养不良患儿,在造血干细胞移植时行包括定量脱髓鞘负荷、DWI、MRS和体积分析的综合MRI方案,中位临床随访5年并按GMFC-MLD和认知表现分为稳定、中度进展和重度进展轨迹。基线脱髓鞘负荷较高、内囊后肢ADC升高及MRS代谢物比值(NAA/Cr和NAA/Cho)较低与重度进展临床过程有统计学显著关联,而基线MRI严重度评分和脑体积无预测价值;纵向体积和病灶指标较弥散和波谱指标更一致地反映移植后疾病演变。
要点
- 移植时较高的定量脱髓鞘负荷、内囊后肢ADC升高及MRS的NAA/Cr、NAA/Cho降低与重度进展轨迹有统计学显著关联。
- 移植时基线MRI严重度评分和脑体积不能预测结局。
- 基线MRS指标可将轻度运动受损(GMFC-MLD=1)患儿回顾性分层为不同结局组,支持早期预后价值。
核心结论
- 青少年异染性脑白质营养不良患儿在造血干细胞移植时的多参数MRI提供互补的预后和纵向信息:基线微结构和代谢异常与长期临床轨迹相关,而移植后纵向疾病演变更一致地由体积和病灶为基础的MRI标志物反映;这些发现支持使用先进MRI生物标志物进行早期风险分层和后续监测,并需进一步评估,包括在接受基因治疗的队列中。
研究设计与样本
- 回顾性、基于注册的队列研究,纳入15例青少年异染性脑白质营养不良患儿,在造血干细胞移植时行综合MRI方案(定量脱髓鞘负荷、DWI、MRS和体积分析),临床随访中位5年,依据GMFC-MLD和认知表现回顾性分为稳定、中度进展和重度进展轨迹。
关键影像表现/征象
- 基线定量脱髓鞘负荷较高、内囊后肢ADC升高及MRS代谢物比值NAA/Cr和NAA/Cho较低与重度进展临床过程有统计学显著关联。
- 纵向分析显示视觉可评估MRI参数(病灶负荷、灰质体积、全脑体积和MRI严重度评分)存在一致的组间差异,在临床轨迹不良的患者中最明显。
- 弥散和波谱指标显示区域和参数特异性的纵向效应,但与体积和病灶指标相比组间分离较弱且不太一致。
诊断标准与关键数值
- 基线较高的定量脱髓鞘负荷、内囊后肢ADC升高和较低的MRS代谢物比值(NAA/Cr和NAA/Cho)与重度进展临床过程有统计学显著关联。
- 基线MRI严重度评分和移植时脑体积不能预测结局。
- 基线MRS指标可将轻度运动受损(GMFC-MLD=1)患儿回顾性分层为不同结局组。
- 纵向组间差异在病灶负荷、灰质体积、全脑体积和MRI严重度评分上一致,且在临床轨迹不良患者中最明显。
临床应用与阅片要点
- 作者认为,这些发现支持使用先进MRI生物标志物进行早期风险分层和后续监测。
- 作者指出,这些发现需进一步评估,包括在接受基因治疗的队列中。
局限性
- 原文在结论中写明这些发现需进一步评估,包括在接受基因治疗的队列中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Clinical outcomes after hematopoietic stem cell transplantation (HSCT) in juvenile metachromatic leukodystrophy (MLD) are variable. This study evaluated whether multiparametric MRI parameters at the time of HSCT can predict long-term clinical outcomes and assessed their longitudinal evolution over an extended follow-up.
MATERIALS AND METHODS: In this retrospective, registry-based cohort study, 15 children with juvenile MLD underwent a comprehensive MRI protocol at HSCT including quantitative demyelination load, DWI, MRS, and volumetric analysis. Patients were followed clinically for a median of 5 years and retrospectively stratified into stabilized, moderately progressive, or severely progressive trajectories based on Gross Motor Function Classification-metachromatic leukodystrophy (GMFC-MLD) and cognitive performance. Baseline imaging metrics and their changes over time were compared across outcome groups.
RESULTS: Higher baseline demyelination load, increased ADC in the posterior limb of the internal capsule, and lower MRS metabolite ratios (NAA/Cr and NAA/Cho) were statistically significantly associated with a severely progressive clinical course. In contrast, baseline MRI severity score and brain volumes at HSCT were not predictive of outcome. Longitudinal analysis demonstrated consistent group differences in visually-assessable MRI parameters, including lesion burden, gray matter volume, total brain volume, and MRI severity score, which were most pronounced in patients with unfavorable clinical trajectories. Diffusion and spectroscopy measures showed region- and parameter-specific longitudinal effects but weaker and less consistent group separation compared with volumetric and lesion-based measures. Notably, baseline MRS metrics allowed retrospective stratification of patients with mild motor impairment (GMFC-MLD = 1) into distinct outcome groups, supporting early prognostic value.
CONCLUSIONS: Multiparametric MRI at the time of HSCT provides complementary prognostic and longitudinal information in juvenile MLD. Baseline microstructural and metabolic abnormalities are associated with long-term clinical trajectories, whereas longitudinal disease evolution after HSCT is more consistently captured by volumetric and lesion-based MRI markers. These findings support the use of advanced MRI biomarkers for early risk stratification and subsequent monitoring and warrant further evaluation, including in gene therapy-treated cohorts.
引用
- Strölin M, Gröschel S, Kehrer C, et al. Multiparametric MRI Analysis of Clinical Outcome after Hematopoietic Stem Cell Transplantation in Juvenile Metachromatic Leukodystrophy. AJNR Am J Neuroradiol. 2026. PMID: 41807041. doi:10.3174/ajnr.A9276
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。